Mobile

A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV

Mise à jour : Il y a 4 ans
Référence : NCT00731471

Femme et Homme

  • | Pays :
  • Senegal
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

This is an open Phase I study of a candidate TB vaccine, MVA85A, in healthy subjects who are infected with HIV. It is designed to study the safety and immunogenicity of the vaccine.

Critère d'inclusion

  • Tuberculosis

Liens